secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2025-07-10T23:59:59+00:00
Accession:  0000950170-25-095029
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos shareholders approve 10x increase in authorized common shares, reverse split authorization
--------------------------------------------------------------------------------

- Stockholders approved increasing authorized common shares from 5M to 50M; amendment effective July 10, 2025.
- Authorized reverse stock split at ratio between 1:5 and 1:20, at Board's discretion.
- Stockholders approved raising shares available under 2020 Equity Incentive Plan from 130,745 to 1,130,745.
- Elected directors: Robert W. Postma, Jaime Vieser, Holger Weis; Dale Hogue resigned before meeting and was not reelected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025095029/0000950170-25-095029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025095029/tcrt-20250703.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-095029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer